Study of Difluprednate in the Treatment of Uveitis

Sirion Therapeutics

Status and phase: Completed; Phase 3

Conditions: Uveitis

Treatments: Drug: Prednisolone Acetate; Drug: Difluprednate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00501579

ST-601A-001

Details and patient eligibility

About

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of endogenous anterior uveitis in at least 1 eye

Exclusion criteria

• Presence of intermediate uveitis, posterior uveitis or panuveitis
• Corneal abrasion
• Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease
• Allergy to similar drugs, such as other corticosteroids